GE HealthCare Technologies, Inc.
name
GE HealthCare Technologies, Inc.
id
GEHC
summary
GE HealthCare Technologies, Inc., doing business as GE HealthCare, is an American multinational medical technology company headquartered in Chicago, Illinois. It was spun-off from General Electric on January 4, 2023, with GE retaining 10.24%. The company is a manufacturer and distributor of diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures. It offers dyes used in magnetic-resonance-imaging procedures; manufactures medical diagnostic equipment, including CT image machines; MRI, XRAY; Ultrasound; Cath Labs; Mammogram; Nuclear Medicine Cameras; and develops Health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing. It was incorporated in 1994 and operates in more than 100 countries. On November 9, 2021, General Electric announced it would split into three investment-grade public companies, with GE HealthCare being one of the three planned divestitures. GE HealthCare completed its spin-off on January 4, 2023, with the company being listed on the Nasdaq Stock Market.
industry
Healthcare
founded
September 28, 1994; 29 years ago (as a subsidiary) January 4, 2023; 14 months ago (as a standalone company)
headquarters
Heller International Building, Chicago, Illinois, U.S.
area_served
Worldwide
key_people
Peter Arduini (CEO), H. Lawrence Culp Jr. (chairman)
revenue
US$19.55 billion (2023)
operating_income
US$2.435 billion (2023)
net_income
US$1.614 billion (2023)
total_assets
US$32.45 billion (2023)
total_equity
US$7.145 billion (2023)
owner
General Electric (10.24%)
number_of_employees
c. 51,000 (2023)
website
gehealthcare.com